Correlation
The correlation between AMGN and MRK is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
AMGN vs. MRK
Compare and contrast key facts about Amgen Inc. (AMGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMGN or MRK.
Performance
AMGN vs. MRK - Performance Comparison
Loading data...
Key characteristics
AMGN:
-0.05
MRK:
-1.32
AMGN:
0.12
MRK:
-1.85
AMGN:
1.02
MRK:
0.75
AMGN:
-0.04
MRK:
-0.86
AMGN:
-0.08
MRK:
-1.51
AMGN:
11.28%
MRK:
24.63%
AMGN:
25.68%
MRK:
27.72%
AMGN:
-78.04%
MRK:
-68.63%
AMGN:
-12.44%
MRK:
-40.85%
Fundamentals
AMGN:
$152.46B
MRK:
$191.84B
AMGN:
$10.97
MRK:
$6.88
AMGN:
25.85
MRK:
11.10
AMGN:
0.94
MRK:
0.70
AMGN:
4.47
MRK:
3.00
AMGN:
24.56
MRK:
3.97
AMGN:
$34.13B
MRK:
$63.92B
AMGN:
$21.50B
MRK:
$51.75B
AMGN:
$12.38B
MRK:
$27.30B
Returns By Period
In the year-to-date period, AMGN achieves a 12.44% return, which is significantly higher than MRK's -22.09% return. Over the past 10 years, AMGN has outperformed MRK with an annualized return of 9.45%, while MRK has yielded a comparatively lower 6.14% annualized return.
AMGN
12.44%
-0.07%
3.61%
-1.17%
7.28%
7.95%
9.45%
MRK
-22.09%
-9.81%
-23.14%
-36.47%
-3.10%
3.07%
6.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMGN vs. MRK — Risk-Adjusted Performance Rank
AMGN
MRK
AMGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AMGN vs. MRK - Dividend Comparison
AMGN's dividend yield for the trailing twelve months is around 3.21%, less than MRK's 4.11% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMGN Amgen Inc. | 3.21% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% | 1.53% |
MRK Merck & Co., Inc. | 4.11% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
AMGN vs. MRK - Drawdown Comparison
The maximum AMGN drawdown since its inception was -78.04%, which is greater than MRK's maximum drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for AMGN and MRK.
Loading data...
Volatility
AMGN vs. MRK - Volatility Comparison
The current volatility for Amgen Inc. (AMGN) is 9.43%, while Merck & Co., Inc. (MRK) has a volatility of 11.25%. This indicates that AMGN experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AMGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Amgen Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMGN vs. MRK - Profitability Comparison
AMGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a gross profit of 5.18B and revenue of 8.15B. Therefore, the gross margin over that period was 63.6%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
AMGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported an operating income of 1.18B and revenue of 8.15B, resulting in an operating margin of 14.5%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
AMGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a net income of 1.73B and revenue of 8.15B, resulting in a net margin of 21.2%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.